Microchip Simplifies the Design of Low-Power LCD Applications
May 31, 2017 12:06 pm UTC| Business
CHANDLER, Ariz., May 31, 2017 -- A new family of low-power microcontrollers (MCUs) for driving Liquid Crystal Displays (LCD) featuring Core Independent Peripherals (CIPs) and intelligent analog is now available from...
Microchip Simplifies the Design of Low-Power LCD Applications
May 31, 2017 12:06 pm UTC| Business
CHANDLER, Ariz., May 31, 2017 -- A new family of low-power microcontrollers (MCUs) for driving Liquid Crystal Displays (LCD) featuring Core Independent Peripherals (CIPs) and intelligent analog is now available from...
Microchip Simplifies the Design of Low-Power LCD Applications
May 31, 2017 12:06 pm UTC| Business
CHANDLER, Ariz., May 31, 2017 -- A new family of low-power microcontrollers (MCUs) for driving Liquid Crystal Displays (LCD) featuring Core Independent Peripherals (CIPs) and intelligent analog is now available from...
Microchip Simplifies the Design of Low-Power LCD Applications
May 31, 2017 12:06 pm UTC| Business
CHANDLER, Ariz., May 31, 2017 -- A new family of low-power microcontrollers (MCUs) for driving Liquid Crystal Displays (LCD) featuring Core Independent Peripherals (CIPs) and intelligent analog is now available from...
Microchip Simplifies the Design of Low-Power LCD Applications
May 31, 2017 12:06 pm UTC| Business
CHANDLER, Ariz., May 31, 2017 -- A new family of low-power microcontrollers (MCUs) for driving Liquid Crystal Displays (LCD) featuring Core Independent Peripherals (CIPs) and intelligent analog is now available from...
KaloBios CEO to Present at Two Upcoming Investor Conferences
May 31, 2017 12:06 pm UTC| Business
BRISBANE, Calif., May 31, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that Cameron...
KaloBios CEO to Present at Two Upcoming Investor Conferences
May 31, 2017 12:06 pm UTC| Business
BRISBANE, Calif., May 31, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that Cameron...